Ads
related to: translocation of chromosome cancer- Programs & Services
Helping Patients Get The Support
They So Desperately Deserve & Need.
- Prostate Cancer Toolkit
Learn more about prostate cancer.
View our recommended resources.
- Give In Honor & Memorial
Honor A Loved One With A Donation.
Support Those Touched By Cancer.
- What Is Prostate Cancer?
Learn more about prostate cancer.
Types of prostate cancer.
- Programs & Services
Search results
Results From The WOW.Com Content Network
In genetics, chromosome translocation is a phenomenon that results in unusual rearrangement of chromosomes. This includes balanced and unbalanced translocation, with two main types: reciprocal, and Robertsonian translocation. Reciprocal translocation is a chromosome abnormality caused by exchange of parts between non-homologous chromosomes. Two ...
The Philadelphia chromosome or Philadelphia translocation (Ph) is a specific genetic abnormality in chromosome 22 of leukemia cancer cells (particularly chronic myeloid leukemia (CML) cells). This chromosome is defective and unusually short because of reciprocal translocation , t(9;22)(q34;q11), of genetic material between chromosome 9 and ...
The first fusion gene [1] was described in cancer cells in the early 1980s. The finding was based on the discovery in 1960 by Peter Nowell and David Hungerford in Philadelphia of a small abnormal marker chromosome in patients with chronic myeloid leukemia—the first consistent chromosome abnormality detected in a human malignancy, later designated the Philadelphia chromosome. [3]
CML was the first cancer to be linked to a clear genetic abnormality, the chromosomal translocation known as the Philadelphia chromosome. This chromosomal abnormality is so named because it was first discovered and described in 1960 by two scientists from Philadelphia, Pennsylvania , US: Peter Nowell of the University of Pennsylvania and David ...
In Burkitt's lymphoma, cancer cells show chromosomal translocations, most commonly between chromosome 8 and chromosome 14 [t(8;14)]. This causes c-Myc to be placed downstream of the highly active immunoglobulin (Ig) promoter region, leading to overexpression of Myc.
This involves the myc oncogene being translocated from chromosome 8 to the Ig kappa locus on chromosome 2. This type of translocation is seen in 15% of cases of Burkitt lymphoma. A rare variant is t(8;22)(q24;q11). [14] This type involves myc oncogene translocation from chromosome 8 to the Ig lambda locus on chromosome 22. This type of ...